Zacks Investment ResearchFri, 10 Jul 2026 19:16:06 GMTReasons Why Investors Should Consider Betting on PTC Stock NowPTCT-4.62%
Zacks Investment ResearchWed, 08 Jul 2026 17:01:07 GMTPTC Therapeutics (PTCT) Upgraded to Strong Buy: Here's What You Should KnowPTCT-4.62%
Zacks Investment ResearchThu, 18 Jun 2026 13:21:03 GMTPTC Therapeutics (PTCT) Moves 7.2% Higher: Will This Strength Last?PTCT-4.62%
Seeking AlphaTue, 09 Jun 2026 17:12:10 GMTPTC Therapeutics, Inc. (PTCT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptPTCT-4.62%
Seeking AlphaTue, 12 May 2026 18:01:02 GMTPTC Therapeutics, Inc. (PTCT) Presents at Bank of America Global Healthcare Conference 2026 TranscriptPTCT-4.62%
Seeking AlphaSun, 10 May 2026 03:21:35 GMTPTC Therapeutics: Sephience Turns The Story From Regulatory Repair To Operating LeveragePTCT-4.62%
Seeking AlphaFri, 08 May 2026 05:51:15 GMTPTC Therapeutics, Inc. (PTCT) Q1 2026 Earnings Call TranscriptPTCT-4.62%
Zacks Investment ResearchThu, 07 May 2026 23:30:17 GMTCompared to Estimates, PTC Therapeutics (PTCT) Q1 Earnings: A Look at Key MetricsPTCT-4.62%
Zacks Investment ResearchThu, 07 May 2026 23:01:18 GMTPTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue EstimatesPTCT-4.62%
Zacks Investment ResearchWed, 06 May 2026 14:15:51 GMTExploring Analyst Estimates for PTC Therapeutics (PTCT) Q1 Earnings, Beyond Revenue and EPSPTCT-4.62%
Zacks Investment ResearchThu, 30 Apr 2026 15:01:34 GMTPTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleasePTCT-4.62%
Seeking AlphaWed, 29 Apr 2026 19:31:32 GMTPTC Therapeutics, Inc. (PTCT) Discusses 24-Month Interim Results of PIVOT-HD Long-Term Extension Study of Votoplam in Huntington's Disease TranscriptPTCT-4.62%
BenzingaWed, 29 Apr 2026 18:48:28 GMTPTC Therapeutics Stock Sinks As Pivotal Data Fails To Calm SellersPTCT-4.62%
